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Background—Whether myocardial perfusion grade (MPG) following late recanalization of infarct-related arteries (IRAs)
predicts left ventricular (LV) function recovery beyond the acute phase of myocardial infarction (MI) is unknown.
Methods and Results—The Total Occlusion Study of Canada-2 enrolled stable patients with a persistently occluded IRA
beyond 24 hours and up to 28 days post-MI. We studied the relationship between the initial MPG and changes in LV
function and volume as well as the change in MPG from immediate post-percutaneous coronary intervention (PCI) to
1 year in 139 PCI patients with thrombolysis in myocardial infarction grade 3 epicardial flow post-PCI and with paired
values grouped into impaired or good MPG groups (MPG 0/1 or MPG 2/3). MPG 0/1 patients were more likely to have
received thrombolytic therapy and to have a left anterior descending IRA. They had lower blood pressure and LV ejection
fraction (LVEF) and a higher heart rate and systolic sphericity index at baseline. Changes in the MPG 0/1 and MPG 2/3 groups
from baseline to 1 year were LVEF, 3.39.0% and 4.88.9% (P0.42); LV end-systolic volume index (LVESVI),
1.19.2 and4.712.3 mL/m2 (P0.25); LV end-diastolic volume index (LVEDVI), 0.0819.1 and2.422.2 mL/m2
(P0.67); and SDs/chord for infarct zone wall motion index (WMI), 0.380.70 and 0.841.11 (P0.01). By covariate-
adjusted analysis, post-PCI MPG 0/1 predicted lower WMI (P0.001), lower LVEF (P0.001), and higher LVESVI
(P0.01) but not LVEDVI at 1 year. Of the MPG 0/1 patients, 60% were MPG 2 or 3 at 1 year.
Conclusions—Preserved MPG is present in a high proportion of patients following late PCI of occluded IRAs post-MI. Poor
MPG post-PCI frequently improves MPG over 1 year. MPG graded after IRA recanalization undertaken days to weeks post
MI is associated with LV recovery, indicating that MPG determined in the subacute post-MI period remains a marker of
viability.
Clinical Trial Registration—URL: http://www.clinicaltrials.gov. Unique identifier: NCT00025766.
(Circ Cardiovasc Interv. 2010;3:549-555.)
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Timely recanalization and sustained patency of the infarct-related artery (IRA) are major determinants of left
ventricular (LV) function and survival after acute myocardial
infarction (MI). Patients with normal epicardial flow in the
IRA (thrombolysis in myocardial infarction [TIMI] grade 3)
but reduced tissue-level perfusion as quantified by TIMI
myocardial perfusion grade (MPG) immediately following
acute reperfusion with fibrinolysis or primary or rescue
percutaneous coronary intervention (PCI)1 have longer
ischemic times, larger infarcts, worse global and regional
LV systolic function, and increased mortality.2,3 These
observations suggest that MPG marks microvascular integ-
rity and is thereby a surrogate for myocardial viability in
the acute phase of MI.4 –7
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In contrast to the extensively documented benefit of early
recanalization, routine late recanalization (beyond 24 hours)
after symptom onset is not well supported by evidence8,9 and is
not guideline recommended. Until recently, late PCI for persis-
tent occlusion generally has been performed on the basis of the
late open artery hypothesis.10 The extent to which effective
microvascular reperfusion can be achieved by PCI performed
after the acute phase and whether it is followed by regional or
global functional recovery of the LV are unknown. The Oc-
cluded Artery Trial (OAT)9 was a multicenter randomized
controlled trial that evaluated the benefit of PCI in addition to
optimal medical therapy compared with optimal medical therapy
alone in patients beyond the first 24 hours and up to 28 days after
MI onset. The Total Occlusion Study of Canada-2 (TOSCA-2)
was a National Heart, Lung, and Blood Institute-funded angio-
graphic ancillary study of OAT with coprimary end points of
IRA patency at 1 year and change in LV ejection fraction (EF)
from baseline to 1 year.8 Paired coronary and LV angiograms
were obtained at baseline and 1 year post-PCI (n332), provid-
ing a unique opportunity to evaluate the association between
MPG at baseline (following successful PCI) and global and
regional functional recovery at 1 year follow-up and to examine
the stability of perfusion grade over time.
Methods
Study Population
The primary results of TOSCA-28 as well as the study design11 and
results9 of the parent OAT have been published. Inclusion criteria for
TOSCA-2 and OAT included a documented index MI and an
occluded IRA (TIMI flow grade 0 or 1) in addition to 1 of 2 high-risk
criteria: (1) proximal occlusion or (2) LVEF 50%. Important
exclusion criteria included a clinical indication for revascularization
(significant angina, severe inducible ischemia, left main or triple-
vessel disease), serum creatinine 2.5 mg/dL, severe valvular
disease, New York Heart Association (NYHA) class III or IV heart
failure, or cardiogenic shock at the time of screening. Inclusion
criteria for the MPG analysis included OAT treatment assignment to
the PCI group with subsequent successful PCI of IRA with post-PCI
antegrade TIMI 3 flow. Finally, baseline, post-PCI, and 1-year
follow-up coronary angiograms suitable for MPG analysis and
analyzable LV angiograms were required.
Data Collection
Baseline characteristics were recorded from the time of index MI to
the time of randomization. Qualifying coronary and LV angiograms
performed after the first 24 hours and up to 28 days post-MI as well
as post-PCI and follow-up angiograms performed after 1 year were
submitted for quantitative analysis performed in a dedicated core
angiographic laboratory. LV volumes, LVEF, regional wall motion,
and sphericity index were calculated as described previously.12–14
PCI
Protocol PCI of the IRA with routine stenting was performed within
24 hours of randomization. All patients received aspirin and either
ticlopidine or clopidogrel beginning the day of the procedure or
earlier. Anticoagulation with heparin during PCI to a target activated
clotting time of 250 seconds was recommended. Use of glycopro-
tein IIb/IIIa inhibitors was encouraged.
MPG
The MPG substudy was prospectively planned, and participating
centers were instructed with respect to technique for obtaining
immediate post-PCI and 1-year follow-up angiograms optimized for
MPG analysis, generally requiring a longer cine-angiographic re-
cording focusing on the myocardial segment likely to demonstrate
blush. MPG was graded semiquantitatively by 2 independent core
laboratory readers (V.J., T.S.) trained to use standard TIMI MPG
criteria1 and blinded to clinical data and timing and sequence of
angiography. In case of discrepancies, angiograms were re-read
independently by both readers, and any remaining discrepancies
were resolved by a third reader (G.B.J.M.). Post-PCI and follow-up
angiograms also were evaluated for residual thrombus and evidence
of distal embolization. The present analysis was limited to patients
with post-PCI TIMI flow grade 3 because it is technically difficult to
grade myocardial blush when the epicardial vessel is poorly opaci-
fied and, moreover, abnormalities of MPG might no longer reflect
microvascular function if flow were restricted proximally. We have
recently published a reproducibility study that included the TIMI
MPG method in an angiographic core laboratory where we found a
high degree of interobserver reproducibility when MPG was dichot-
omized to 0 or 1 versus 2 or 3.15 Because of the relatively small
number of patients in the present study and the inherent difficulties
in MPG grading, we prospectively defined grouping of MPG to 0 or
1 (MPG 0/1) versus 2 or 3 (MPG 2/3).
Statistical Analysis
Categorical variables are expressed as frequencies and percentages and
continuous variables as meanSDs. Categorical variables were com-
pared using 2 test or, alternatively, Fisher exact test if expected
frequency for any cell in a 22 table was 5. The Wilcoxon 2-sample
test was used to compare time intervals from index MI to baseline
angiography, randomization, and PCI. Independent-sample t test was
used to compare other continuous variables that were normally distrib-
uted. Within-group changes over time were compared using a paired t
test of the difference, and between-group differences were compared
with 2-sample t tests. The prespecified level of significance for all
secondary analyses of OAT was P0.01, whereas P0.01 and 0.05
were considered to indicate a trend toward statistical significance.
Effects of impaired post-PCI MPG (MPG 0/1) on 1-year LVEF, wall
motion index (WMI), LV end-systolic volume index (LVESVI), and
LV end-diastolic volume index (LVEDVI) were examined in an
unadjusted as well as a covariate-adjusted linear regression model. All
baseline covariates that were tested for are listed in Table 1 of the main
OAT publication.9 Adjustments were made for other baseline covari-
ates, with P0.05 on multiple linear regression using backward elimi-
nation. WMI was adjusted for baseline WMI, days to randomization,
body mass index (BMI), and new Q waves. LVEF was adjusted for
baseline LVEF, heart rate, BMI, and new Q waves. LVESVI was
adjusted for baseline LVESVI, no family history, NYHA class I at
presentation, and left anterior descending artery (LAD) as the IRA.
Results
Distribution of MPG
Of the 381 patients enrolled in TOSCA-2, 195 were assigned to
PCI, and of these, 186 had angiograms potentially suitable for
baseline MPG analysis. The 9 angiograms that were excluded
had cine-angiographic recordings that were too short for analy-
sis. The distribution of post-PCI TIMI flow grade in these 186
patients was grade 0 in 12 (6.5%), grade 1 in 6 (3.2%), grade 2
in 11 (5.9%), and grade 3 in 157 (84.4%). The distribution of
MPG, evaluated in all 157 patients with TIMI flow grade 3, was
MPG 0 in 25 (15.9%), MPG 1 in 8 (5.1%), MPG 2 in 77
(49.0%), and MPG 3 in 47 (29.9%). Baseline clinical character-
istics of the MPG 0/1 and MPG 2/3 groups are provided in Table 1,
and angiographic and procedural characteristics are provided in
Table 2. Of these 157 evaluable patients, 142 also had MPG and
global and regional LV functional parameters suitable for
analysis at 1-year follow-up. Paired analyses were available for
139 patients (post-PCI and 1 year).
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Univariate Correlates of Impaired MPG Post-PCI
At baseline, patients with MPG 0/1 had evidence of larger
infarcts, lower systolic blood pressure and LVEF, and a trend to
a larger LVESVI and higher peak creatine kinase compared with
patients with MPG 2/3. They also were more likely to have an
occluded LAD and to have been treated with fibrinolytic therapy
for the index MI and less likely to have angiographically visible
collaterals. Glycoprotein IIb/IIIa inhibitors were used in a
majority of cases, with no difference between groups (Tables 1
and 2). These baseline findings are similar to those reported for
the larger cohort of 261 OAT ancillary study patients in whom
baseline MPG was measured.16
Optimal Medical Treatment
Both MPG groups had high rates of optimal medical therapy
during hospital stay, at discharge, and at 1-year follow-up,
with no differences observed between the groups (Table 3).
Changes in LV Size and Function Over 1 Year
As a group, patients with MPG 2/3 showed significant improve-
ment at follow-up in measures of global contractility, including
LVEF and LVESVI. In contrast, those with MPG 0/1 showed no
improvement. The more demanding between-group comparison
testing for differential effects of post-PCI MPG on these LV
parameters, however, was not significant (Figure A and B).
Regional contractility of the infarct zone as expressed by the
wall motion score improved in both MPG groups at follow-up,
but the degree of wall motion improvement observed in the
MPG 2/3 group was significantly greater than that observed in
the MPG 0/1 group (Figure D). No significant change or
Table 1. Baseline Clinical Characteristics by Post-PCI MPG
Characteristic
Post-PCI
MPG 0/1
(n33)
Post-PCI
MPG 2/3
(n124) P
Male sex, % 78.8 85.5 0.350
Age, y 54.69.2 57.410.5 0.174
BMI, kg/m2 28.64.5 27.64.1 0.21
Diabetes 24.2 16.9 0.336
Hypertension 48.5 50.8 0.813
Hyperlipidemia 48.5 58.9 0.285
Family history of CAD 42.4 48.4 0.542
Current-smoker 42.4 31.5 0.236
Prior angina 12.1 21.8 0.216
Prior MI 6.1 13.7 0.368
Interval from MI to baseline
angiogram, d
5 (4, 8) 5 (3, 9) 0.566
Interval from MI to
randomization, d
9 (5, 17) 10 (6, 20) 0.512
Interval from MI to PCI, d 10 (5, 18) 10 (7, 20) 0.507
Interval from baseline
angiogram to PCI, d
3 (0, 9) 2 (0, 12) 0.939
Heart rate, beats/min 74.912.1 67.410.9 0.001
Systolic blood pressure,
mm Hg
108.416.5 119.315.1 0.0004
Diastolic blood pressure,
mm Hg
66.99.7 72.110.8 0.014
Fibrinolytic therapy during
first 24 h of index MI
45.4 16.9 0.001
ST elevation 0.1 mV 72.7 59.8 0.175
ST depression 0.1 mV 36.4 30.3 0.508
New Q waves 63.4 65.3 0.860
Maximum pre-PCI total CK
divided by ULN
10.16.2* 7.17.3† 0.048
Maximum pre-PCI CK MB
divided by ULN
23.426.6 11.814.3 0.123
Maximum pre-PCI TNI
divided by ULN
172.4152.0 271.4713.6 0.253
Maximum pre-PCI TNT
divided by ULN
229.5215.9 50.650.3 0.138
Killip class 1 during
index MI
9.1 10.5 0.999
NYHA class I at
randomization
9.1 6.4 0.700
Data are presented as meanSD, median (interquartile range), or percent-
age. CAD indicates coronary artery disease; CK, creatine kinase; TNI, troponin
I; TNT, troponin T; ULN, upper limit of the local laboratory normal.
*n27.
†n104.
Table 2. Angiographic and Procedural Characteristics by
Post-PCI MPG
Characteristic
Post-PCI
MPG 0/1 (n33)
Post-PCI
MPG 2/3
(n124) P
Pre-PCI coronary angiography
LAD IRA 54.6 21.8 0.001
Circumflex IRA 21.2 9.7
RCA IRA 24.2 68.5
IRA TIMI flow grade 0 to 1 100.0 98.4 1.000
Collaterals present 72.3 95.1 0.001
Single-vessel disease 87.9 81.4 0.385
Pre-PCI LV angiography
Infarct segment regional
WMI SD/chord
3.20.7 2.91.0 0.177
LVEF 42.611.6 50.68.7 0.001
LVESVI 39.820.1 31.314.3 0.08
LVEDVI 69.727.3 63.624.7 0.34
Diastolic sphericity index 31.05.3 30.86.4 0.862
Systolic sphericity index 25.36.1 22.95.5 0.035
Mitral regurgitation present 28.1 35.8 0.414
Procedural characteristics and
post-PCI angiography
Residual thrombus 9.1 2.4 0.108
Distal embolization 3.0 8.9 0.462
Post-PCI residual %
diameter stenosis
29.817.6 27.814.3 0.507
Post-PCI minimal
luminal diameter, mm
2.20.6 2.30.5 0.097
Glycoprotein IIb/IIIa
inhibitors used
90.9 83.1 0.27
Stent implanted 100.0 99.2 1.000
Data are presented as meanSD or percentage. RCA indicates right
coronary artery.
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difference was noted within or between MPG groups for
LVEDVI (Figure C). We also observed a significantly lower
systolic sphericity index at 1 year in the MPG 2/3 (0.206) versus
the MPG 0/1 (0.240) group (P0.008).
Changes in MPG Over 1 Year
Of the 109 MPG 2/3 group patients, 18 (17%) had MPG 0 or 1
at 1 year (Table 4). Binary restenosis in the IRA was observed
in 16 (88.9%) of these patients and in 27 (29.7%) of 91 patients
in whom MPG remained 2 or 3 (P0.0001). Mean diameter
stenosis was 82.522.8% versus 43.920.4% (P0.0001) in
these 2 groups. Of the post-PCI MPG 0/1 group, 60% had MPG
2 or 3 at 1 year. Among the 30 MPG 0/1 group patients with
angiographic follow-up, restenosis was observed in 9 (50%) of
the 18 with MPG 2 or 3 at 1 year and 3 (25%) of 12 with
persistent MPG 0 or 1 (P0.17).
Independent Correlates of LV Size and Function
at 1 Year (by Post-PCI MPG)
On multivariable analysis (Table 5) post-PCI MPG 0/1
predicted lower WMI (P0.0002) and LVEF (P0.0008)
and a higher LVESVI (P0.0056) at 1 year.
Figure. Comparison of baseline (post-
PCI) and follow-up at 1 year of LVEF (A).
LVESVI (B), LVEDVI (C), and target
region wall motion (SD/chord) (D)
between groups (MPG 0/1 versus MPG
2/3) (paired data). Values are given for
change within group and P values for
within-group and between-group com-
parisons. ED indicates end diastolic; ES,
end systolic.
Table 3. Use of Medical Therapies at Discharge and at 1 Year (by MPG)
Discharge 1-Year Follow-Up
MPG 0/1
(n30)
MPG 2/3
(n109) P
MPG 0/1
(n29)
MPG 2/3
(n106) P
Discharge
Aspirin 29 (96.7) 108 (99.1) 0.39 28 (96.6) 100 (94.3) 1.00
Thienopyridines (clopidogrel or
ticlopidine)*
30 (100.0) 108 (99.1) 1.00 9 (31.0) 29 (27.4) 0.70
Aspirin or thienopyridine 30 (100.0) 109 (100.0) NA 28 (96.6) 103 (97.2) 1.00
Aspirin plus thienopyridine 29 (96.7) 107 (98.2) 0.52 9 (31.0) 26 (24.5) 0.48
Warfarin 5 (16.7) 4 (3.7) 0.02 … … …
One or more of aspirin,
warfarin, thienopyridine
30 (100.0) 109 (100.0) NA … … …
Two or more of aspirin,
warfarin, thienopyridine
30 (100.0) 107 (98.2) 1.00 … … …
-blocker 28 (93.3) 97 (89.0) 0.73 28 (96.6) 89 (84.0) 0.12
ACE inhibitor or ARB 29 (96.7) 94 (86.2) 0.19 28 (96.6) 92 (86.8) 0.19
Spironolactone 4 (13.3) 2 (1.8) 0.02 4 (13.8) 6 (5.7) 0.22
Lipid-lowering agent 28 (93.3) 92 (84.4) 0.37 28 (96.6) 93 (87.7) 0.30
Data are presented as no. (%). ACE indicates angiotensin-converting enzyme; ARB, angiotensin receptor blocking agent.
*Only clopidogrel for 1-year follow-up.
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Discussion
This study addresses the ability of MPG to discriminate among
patients with successful PCI of occluded infarct arteries and
those who will have favorable changes in LV function from
those who will not. To our knowledge, this study is the first to
address the association between MPG and global and regional
recovery of LV function following late recanalization of the IRA
after MI and to describe MPG at 1-year follow-up.
The study population was uniformly selected and uniquely
suited to test MPG as a predictor of LV recovery post-MI.
OAT-enrolled, stable patients with occluded IRAs underwent
recanalization with PCI/stent. We selected only patients with
normal epicardial flow immediately post-PCI after a median
occlusion time of 10 days. Notably, 79% of our cohort
demonstrated MPG 2 or 3. Extending the results of studies
examining acute reperfusion cohorts, preserved MPG was
significantly associated with better indices of LV systolic
function at 1 year (Figure). We also observed that MPG
improved significantly from post-PCI to follow-up at 1 year.
Distribution of MPG
Our results are consistent with a large study of early recan-
alization by primary PCI with good epicardial and microvas-
cular flow in 1190 (76.9%) of 1548 patients.17 In a recent
publication on thrombus aspiration in the setting of acute MI,
75% to 82% of patients had myocardial blush grade 2 or 3.18
Both of these studies used myocardial blush grade,17 which,
although it uses somewhat different criteria, is angiographi-
cally and conceptually similar to the MPG system used in the
present study. The results are comparable to the 79% preva-
lence following successful late recanalization after the first 24
hours and up to 28 days post-MI in the present study.
Several factors may be responsible for the high rates of
preserved MPG following late PCI in the present study. We
selected only patients with TIMI 3 flow post-PCI, as ex-
plained in the Methods section. Stents were implanted in
nearly all (99.4%) patients, and angiographic evidence of
residual thrombus and distal embolization was seen only in a
very small number of patients. Finally, the myocardial edema
and microvascular plugging by aggregates of leukocytes and
platelets, typical of acute MI, may have begun to resolve in
many of our patients. Rochitte and colleagues19 showed that
the extent of microvascular obstruction increases over the
first 48 hours after experimental acute MI and reperfusion in
canines. The same group reported that the peak extent of
microvascular obstruction occurs 2 days after reperfusion and
is unchanged at 9 days.20 Using coronary Doppler ultrasound,
Hozumi and coworkers,21 reported a short deceleration time
of diastolic flow velocity (DDT), a measure of microvascular
resistance, 1 day after IRA recanalization, indicating poor
runoff in the microcirculation. Interestingly, they found
significantly longer DDT, indicating lower microvascular
resistance, 1 and 2 weeks after acute IRA recanalization in a
group with viable myocardium and a group with nonviable
myocardium in the region of interest. In both groups, the
DDT normalized by 2 weeks after recanalization. The authors
postulated that after the first 2 days following reperfusion,
there is a gradual recanalization of the occluded microvessels,
causing a progressive decrease in coronary resistance, even in
areas without viable myocardium. In support of this hypoth-
esis, we observed an increase in the number of patients
showing MPG 2 or 3 at 1 year compared with post-PCI. In
light of these data, it seems clear that poor blush can improve,
indicating that it does not always imply irreversible necrosis
of the microvasculature even if the subtended myocardium is
substantially infarcted. The change in MPG from good to
worse is associated with severe restenosis in the IRA,
suggesting that parts of the microcirculation in areas with scar
tissue may occlude spontaneously over time in the presence
of severe restenosis, even if the epicardial artery remains
patent with TIMI 3 flow. Alternatively, assessment of MPG
in the presence of a severe upstream stenosis, particularly in
a previously infarcted region, may be unreliable.
Functional Recovery in the Context of
TOSCA-2 Results
In TOSCA-2, significant improvement in LVEF was observed at
1 year in both medically treated and PCI patients of about the
same magnitude as in the MPG 2/3 group in the present substudy
(4.88.9%).8 The MPG 0/1 subgroup likely had more densely
infarcted myocardium and microvascular derangement as evi-
denced by the significantly lower LVEF and larger volumes just
a few days post-MI. As already stated, however, it does not
appear that, if poor myocardial perfusion represents a larger
infarct and microvascular derangement, this derangement is
entirely irreversible. In addition, improvement in LVEF ap-
Table 4. Changes in MPG Over 1 Year
Post-PCI MPG
1-Year MPG
TotalMPG 0/1 MPG 2/3
MPG 0/1 12 (40) 18 (60) 30 (22)
MPG 2/3 18 (17) 91 (83) 109 (78)
Total 30 (22) 109 (78) 139 (100)
Data are presented as no. (%). P0.006 for changes.
Table 5. Effects of Post-PCI MPG 0/1 Versus Post-PCI MPG
2/3 on LV Outcome Measures at 1 Year
Variable
Parameter
Estimate SEM T P
Unadjusted
Infarct segment regional
WMI (n118)
0.67 0.23 2.90 0.0045
LVEF (n126) 8.86 1.92 4.60 0.0001
LVESVI (n76) 7.23 3.14 2.30 0.023
LVEDVI (n76) 4.66 5.34 0.87 0.39
Covariate adjusted
Infarct segment regional
WMI
0.71 0.18 3.89 0.0002
LVEF 5.75 1.67 3.43 0.0008
LVESVI 7.16 2.50 2.86 0.0056
LVEDVI 4.49 4.81 0.93 0.35
WMI adjusted for baseline WMI, days to randomization, BMI, and new Q
waves. LVEF adjusted for baseline EF %, heart rate, BMI, and new Q waves.
LVESVI adjusted for baseline LVESVI, no family history, NYHA classI, and LAD
culprit. LVEDVI adjusted for baseline LVEDVI, baseline LVEF, and LAD culprit.
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peared to be attenuated in the MPG 0/1 subgroup but was not
significantly different from the MPG 2/3 subgroup, and the
target regional wall motion score significantly increased in the
MPG 0/1 subgroup, which means that there is some viability
retained, even with poor blush immediately post-PCI.
Rather, early poor perfusion may represent a larger extent
of injury causing microvascular dysfunction and early ven-
tricular dilation that has potential for recovery over time. This
notion is further supported by the OAT nuclear ancillary
study22 in which improvement in LVEF over 1 year was
predicted by baseline infarct zone viability.
Infarct Size and MPG
Patients with baseline clinical and angiographic features of
larger infarct size subsequently exhibited impaired MPG follow-
ing PCI in agreement with previous studies, suggesting that
infarct size is closely related to microvascular obstruction
despite restoration of epicardial patency.23,24 Infarct size was
shown to be a major determinant of reflow following release of
coronary occlusion in an experimental model of coronary occlu-
sion and recanalization.24 We found fewer collaterals, signifi-
cantly more LAD occlusions, and a greater likelihood of unsuc-
cessful fibrinolytic therapy in the MPG 0/1 group. These
findings are similar to those reported for the larger cohort of 261
OAT ancillary study patients in whom baseline MPG was
measured16 and in correspondence with data published by
Kandzari et al26 from a study of primary percutaneous revascu-
larization in acute MI, showing that anterior infarction is
associated with greater impairment of LVEF, less frequent
collateral flow, and diminished reperfusion success as measured
by MPG.
We reported in our previous publication16 that failed fibrino-
lytic therapy was significantly associated with impaired MPG
following late recanalization of occluded IRAs by PCI. The
association was no longer significant when adjusted for multiple
variables that correlate with infarct size, suggesting that impaired
post-PCI MPG in patients with failed fibrinolytic therapy is
mainly related to larger infarct size, and we may speculate that
fibrinolytic therapy is preferentially administered to more criti-
cally ill patients. Thus, the higher frequency of impaired MPG in
patients with LAD occlusion may be related to larger infarcts in
these patients. Absence of collaterals, noted more often with
LAD occlusion, may have further contributed to higher fre-
quency of impaired MPG in this subset.
Limitations
Myocardial perfusion as assessed by contrast angiography is
semiquantitative and might be considered a difficult parameter
to adjudicate. However, we have recently published a reproduc-
ibility study that included the TIMI MPG method in an angio-
graphic core laboratory.15 We found a high degree of interob-
server reproducibility when MPG was dichotomized to 0 or 1
versus 2 or 3; thus, we prospectively defined the grouping as
MPG 0/1 versus MPG 2/3. The study population in TOSCA-2
was relevant to examining the benefit of routine late PCI
compared with medical therapy alone in patients with occluded
IRAs post-MI, and the results cannot be extrapolated to all
patients undergoing late PCI after MI. We analyzed MPG only
in the subset of this population with antegrade TIMI 3 flow after
late IRA recanalization. Follow-up coronary angiography may
reflect ascertainment bias, with sicker patients not returning.
Therefore, it is unknown whether the reported findings in a
subset of patients extend to the entire cohort.
Conclusions
Preserved MPG is present in the majority of patients with MI
with normal epicardial flow following late PCI recanalization of
their occluded IRA. Impaired baseline MPG is associated with
unfavorable LV indices, whereas preserved baseline MPG in our
cohort is associated with segmental and global LV recovery.
This observation extends prior analyses undertaken in acute MI
settings and is consistent with favorable MPG marking retained
viability within the infarct zone. Finally, patients with poor
baseline MPG frequently show MPG improvement and signifi-
cantly, but modestly improved wall motion over 1 year and,
thus, a relative lack of LV functional improvement. These data
suggest that microvascular integrity and myocardial viability can
be disengaged from each other in the chronic post-MI phase and
warrant further study.
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CLINICAL PERSPECTIVE
The extent to which effective microvascular perfusion can be achieved by percutaneous coronary intervention (PCI)
performed after the acute phase of a myocardial infarction (MI) and whether the magnitude of microvascular perfusion
affects left ventricular (LV) recovery is unknown. The Total Occlusion Study of Canada-2, an ancillary study of the
2166-patient Occluded Artery Trial, enrolled 381 stable patients with a persistently occluded infarct-related artery (IRA)
days to weeks post-MI to PCI or medical therapy alone. Change in myocardial perfusion grade (MPG) was determined
from immediate post-PCI to 1 year follow-up (157 patients), and the relationship between initial MPG and LV function
and volume was assessed in 139 patients. Preserved MPG was present in the majority of patients with normal epicardial
flow following late PCI recanalization of the IRA. Impaired baseline MPG was associated with unfavorable LV indices,
whereas preserved baseline MPG was associated with segmental and global LV recovery. Patients with poor baseline MPG
frequently showed MPG improvement and significantly, but only modestly improved wall motion over 1 year. Thus,
microvascular integrity and myocardial viability can be disengaged from each other in the chronic post-MI phase, but
subgroups of stable patients with areas of viable myocardium might benefit from late recanalization. Preserved MPG
immediately post-PCI may be associated with LV recovery.
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